Invigor’s TillerStack scores over $820k in new contracts


Published 07-NOV-2018 10:26 A.M.


2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.

Click Here to View Latest Articles

Leading data and analytics solutions company, Invigor Group (ASX:IVO), has updated the market on the business operations of its 100% owned German subsidiary, TillerStack.

Pleasingly, TillerStack has locked in over $820,000 in new contracts. This includes an R&D project for a major industry association based in Germany, as well as renewal of an existing contract with UnityMedia, with revenue to be booked this calendar year.

TillerStack provides sophisticated field service software solutions for major enterprises across Europe. Field Service Management (FSM) software is integral to any business that delivers services as part of their normal operations.

Beyond digitising workflows for dispatchers and mobile workers out in the field, TillerStack’s FSM software reduces service operating costs, improves worker efficiency, and delivers an exceptional customer experience by improving critical service metrics such as ‘time to fix’ and ‘first time fix’ rates.

Gartner has estimated the value of FSM software and associated services at over $2.8 billion globally in 2017, up 21% from 2016.

As to the specifics of its contract wins, TillerStack has secured one new contract and one extension of a current contract, with the combined value of approximately $820,000 (€520,000). These form part of the $1.35 million of new contract wins forecasted and announced in late October.

The new contracts include:

  • A 2.5 year, $649,000 (€410,000) R&D project for the development of field service solutions for Central Association for Sanitation, Heating and Climate eV in conjunction with The Society for Social Business Consulting. TillerStack was selected for its innovative and agile solutions that have been tried and tested across major enterprises. This project provides a major catalyst to further develop the current solution suite for small/medium-sized businesses.
  • Expansion of an existing contract with leading telecommunications company, UnityMedia, valued at $174,000 (€110,000). TillerStack will enhance the current technology platform to provide a better user experience through improved reporting for dispatchers at headquarters and mobile technicians in the field.

TillerStack CEO, Leslie Cohen, said: “TillerStack was established as a separate entity in May 2018 and since this time, the team has significantly strengthened the customer base, expanded current contracts and substantially lowered the cost base.

“The business is also capitalising on growing demand for and increased adoption of field service solutions in the SME market that is being driven by more affordable and agile solutions such as ours.

“The R&D contract enables us to fast-track growth in this market and pursue a whole new revenue channel. We are excited to capitalise on the increasing growth rates in the field services market and will be focused on innovating and leveraging our position to do so,” added Cohen.

Cohen noted that the company is also progressing a number of other tenders and strategic partnerships to strengthen its presence in Europe.

“The tendering pipeline is healthy,” he said.

General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.


Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free